Cancer patients less likely to receive life-saving therapy when suffering a heart attack
A major study of nearly 2 million heart attack patients has found that many who also had cancer were not offered a potentially lifesaving treatment, despite the fact it had major benefits.
The international research team, led by Keele s Professor Mamas Mamas and the Keele Cardiovascular Research Group, analyzed data from 1.8 million patients who presented with a ST-elevation myocardial infarction (STEMI) - a type of heart attack -to investigate whether patients who also have cancer gain as much benefit from receiving a treatment called Percutaneous Coronary Intervention, as those without cancer during their heart attack.